New antibiotics are needed to treat drug-resistant Mycobacterium tuberculosis infections. Richard Lee and his colleagues now report a new series of semisynthetic spectinomycin analogs that show promise as potentially safe and effective antitubercular drug candidates.
- Richard E Lee
- Julian G Hurdle
- Anne J Lenaerts